Journal
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
Volume 18, Issue 7, Pages 1763-1769Publisher
AMER SCIENTIFIC PUBLISHERS
DOI: 10.1166/jbn.2022.3390
Keywords
Adriamycin; Niosome; Liver Cancer; Drug Delivery
Funding
- Zhejiang Provincial Natural Science Foundation of China
- Medicine and Health Sci- ence and Technology Plan Projects of Zhejiang Province
- [LY21H160016]
- [2021KY231]
Ask authors/readers for more resources
This study investigated the application of Adriamycin-loaded niosomes in the treatment of liver cancer. The results demonstrated that Adriamycin-loaded niosomes improved cellular uptake of Adriamycin, enhanced its anti-cancer effect in vivo, and reduced the toxicity to normal cells and mortality in tumor-bearing mice through responsive release under acidic conditions.
The delivery efficiency of Adriamycin is crucial for the therapy of hepatocellular carcinoma. Niosome is a promising carrier that can be used for targeted drug delivery. However, the therapeutic effect of Adriamycin loaded niosome is still unclear. In this study, Adriamycin loaded niosomes were constructed as a promising drug carrier system. The morphological determination of niosomes was conducted by transmission electron microscopy. Cell fluorescence was used for cellular uptake analysis. Western blotting was used to estimate the apoptosis-related protein expression in HepG2 cells. 3-(4,5)-di-methylthiahiazo(-z-y1)-3,5-di-phenytetrazolium bromide assay was used for estimating the apoptosis of cancer cells. The in vivo anti-cancer effect and safety of Adriamycin loaded niosomes were analyzed in tumor-bearing mice. Adriamycin loaded niosomes improved the cellular uptake of Adriamycin. The anti-cancer effect of Adriamycin in vivo was enhanced. The responsive release of Adriamycin loaded niosomes under acidic conditions reduced the toxicity of Adriamycin to IP 846247 10 On: Mon, 2 De 2022 06:1449 normal cells and the mortality of tumor-bearing mice. Together, Adriamycin loaded niosomes improved its anti-cancer Copyright Am rican Sc entific Pubishers effect and safety for liver cancer treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available